We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$25.5B
AUM Growth
-$11.1B
Cap. Flow
-$5.25B
Cap. Flow %
-20.57%
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.44%
2 Technology 14.21%
3 Industrials 12.1%
4 Healthcare 9.72%
5 Financials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
2001
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$584K ﹤0.01%
+6,000
New +$709K
IRM icon
2002
PUT
Iron Mountain
IRM
$36.3B
$583K ﹤0.01%
18,000
-3,300
-15% -$108K
LYTS icon
2003
LSI Industries
LYTS
$913M
$583K ﹤0.01%
184,022
-12,809
-7% -$53.4K
VALE icon
2004
CALL
Vale
VALE
$62.6B
$583K ﹤0.01%
+44,200
New +$632K
CAR icon
2005
PUT
Avis
CAR
$4.89B
$580K ﹤0.01%
25,800
+18,800
+269% +$546K
EVR icon
2006
Evercore
EVR
$12B
$580K ﹤0.01%
+8,109
New +$666K
ATTO
2007
DELISTED
Atento S.A.
ATTO
$580K ﹤0.01%
28,755
+16,734
+139% +$480K
CMPR icon
2008
CALL
Cimpress
CMPR
$2.34B
$579K ﹤0.01%
5,600
+400
+8% +$46.4K
BRSL
2009
PUT
Brightstar Lottery PLC
BRSL
$2.03B
$578K ﹤0.01%
+39,500
New +$653K
IRBT
2010
PUT
DELISTED
iRobot
IRBT
$578K ﹤0.01%
6,900
+400
+6% +$36.3K
SYF icon
2011
PUT
Synchrony
SYF
$25.6B
$577K ﹤0.01%
24,600
+17,800
+262% +$482K
ALDR
2012
DELISTED
Alder Biopharmaceuticals
ALDR
$577K ﹤0.01%
+56,298
New +$721K
ELGX
2013
DELISTED
Endologix Inc
ELGX
$576K ﹤0.01%
80,421
+26,445
+49% +$295K
OLN icon
2014
PUT
Olin
OLN
$2.14B
$573K ﹤0.01%
28,500
+18,500
+185% +$395K
CCXI
2015
DELISTED
ChemoCentryx, Inc.
CCXI
$571K ﹤0.01%
52,362
-88,419
-63% -$932K
HOLI
2016
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$566K ﹤0.01%
+32,319
New +$616K
APEI icon
2017
American Public Education
APEI
$931M
$565K ﹤0.01%
19,859
-48,797
-71% -$1.5M
ARCO icon
2018
Arcos Dorados Holdings
ARCO
$1.76B
$565K ﹤0.01%
73,554
-128,732
-64% -$918K
COGT icon
2019
Cogent Biosciences
COGT
$7.14B
$565K ﹤0.01%
+32,086
New +$949K
PANW icon
2020
PUT
Palo Alto Networks
PANW
$293B
$565K ﹤0.01%
18,000
-24,000
-57% -$748K
CLUB
2021
DELISTED
Town Sports International Holdings, Inc.
CLUB
$565K ﹤0.01%
88,248
-10,290
-10% -$77.8K
NVRI icon
2022
Enviri
NVRI
$630M
$564K ﹤0.01%
28,416
+17,405
+158% +$432K
BDX icon
2023
PUT
Becton Dickinson
BDX
$48.8B
$563K ﹤0.01%
2,563
-10,045
-80% -$2.33M
CWH icon
2024
CALL
Camping World
CWH
$644M
$563K ﹤0.01%
+49,100
New +$871K
HES
2025
CALL
DELISTED
Hess
HES
$563K ﹤0.01%
13,900
-16,100
-54% -$918K

Similar funds

Two Sigma Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.

  • Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
  • Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
  • Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
  • Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
  • Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
  • Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
  • Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.